130 related articles for article (PubMed ID: 11201021)
1. Coexistence of factor V Leiden and primary antiphospholipid syndrome: a patient with recurrent myocardial infarctions and thrombocytopenia.
Schütt M; Klüter H; Wiedemann GJ; Richardt G
Z Kardiol; 2000 Dec; 89(12):1067-71. PubMed ID: 11201021
[TBL] [Abstract][Full Text] [Related]
2. Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?
Berman H; Ugarte-Gil MF; Espinosa G; Tàssies D; Monteagudo J; Reverter JC; Cervera R
Clin Exp Rheumatol; 2013; 31(6):926-32. PubMed ID: 24093662
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid syndrome and factor V Leiden. Three cases with recurrent venous thrombosis.
Guis-Sabatier S; Roudier J; Arnoux D; Rochwerger A; Roux H; Mattei JP
Joint Bone Spine; 2000; 67(2):134-6. PubMed ID: 10769107
[TBL] [Abstract][Full Text] [Related]
4. Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation.
Dori D; Beiran I; Gelfand Y; Lanir N; Scharf J; Miller B; Brenner B
Am J Ophthalmol; 2000 Jan; 129(1):106-8. PubMed ID: 10653428
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune hepatitis associated with coagulation disorders and immunethyreopathy.
Benten D; Widjaja A; von Depka M; Flemming P; Trautwein C; Böker K; Vogel A; Rosenau J; Manns MP
Z Gastroenterol; 2001 Oct; 39(10):837-40. PubMed ID: 11605152
[TBL] [Abstract][Full Text] [Related]
6. [Myocardial infarction as an initial symptom of antiphospholipid syndrome, factor V Leiden mutation, and hyperhomocysteinemia].
Dropiński J; Wegrzyn W; Szczeklik W; Krzanowski M
Pol Arch Med Wewn; 2004 Jan; 111(1):63-7. PubMed ID: 15088423
[TBL] [Abstract][Full Text] [Related]
7. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
[TBL] [Abstract][Full Text] [Related]
8. [Factor V Leiden and myocardial infarction: a case, review of the literature with a meta-analysis].
Doix S; Mahrousseh M; Jolak M; Laurent Y; Lorenzini JL; Binquet C; Zeller M; Cottin Y; Wolf JE
Ann Cardiol Angeiol (Paris); 2003 Jun; 52(3):143-9. PubMed ID: 12938565
[TBL] [Abstract][Full Text] [Related]
9. Factor V Leiden mutation and antiphospholipid syndrome: risk factors for atherosclerotic and arterial thromboembolic disease.
Thakor AS; Shah D; Miller F; Gaunt ME
J Vasc Interv Radiol; 2009 Aug; 20(8):1097-8. PubMed ID: 19574060
[No Abstract] [Full Text] [Related]
10. Arterial thrombosis and acute myocardial infarction with angiographically normal coronary arteries in a woman heterozygous for both factor V Leiden and prothrombin mutation.
Gaspar J; Benchimol C; Gadelha T; Penna GL
Rev Port Cardiol; 2011 Sep; 30(9):727-9. PubMed ID: 21958997
[TBL] [Abstract][Full Text] [Related]
11. Familial coexistence of primary antiphospholipid syndrome and factor VLeiden.
Schütt M; Klüter H; Hagedorn-Greiwe M; Fehm HL; Wiedemann GJ
Lupus; 1998; 7(3):176-82. PubMed ID: 9607641
[TBL] [Abstract][Full Text] [Related]
12. Coagulation management of a patient with factor V Leiden mutation, lupus anticoagulant, and activated protein C resistance: a case report.
Stammers AH; Dorion RP; Trowbridge C; Yen B; Klayman M; Murdock JD; Woods E; Gilbert C
Perfusion; 2005 Mar; 20(2):115-20. PubMed ID: 15918449
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
DeSancho MT; Berlus N; Christos PJ; Rand J
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction.
Middendorf K; Göhring P; Huehns TY; Seidel D; Steinbeck G; Nikol S
Am Heart J; 2004 May; 147(5):897-904. PubMed ID: 15131548
[TBL] [Abstract][Full Text] [Related]
15. Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.
Quincampoix JC; Legarff M; Rittling C; Andiva S; Toulon P
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):569-76. PubMed ID: 11685046
[TBL] [Abstract][Full Text] [Related]
16. Effect of dabigatran on a prothrombinase-based assay for detecting activated protein C resistance: an ex vivo and in vitro study in normal subjects and factor V Leiden carriers.
Gessoni G; Valverde S; Valle L; Caruso P; Gessoni F; Valle R
Blood Transfus; 2017 Oct; 15(6):562-567. PubMed ID: 28287382
[TBL] [Abstract][Full Text] [Related]
17. [Recurrent coronary thrombosis, factor V Leiden, primary antiphospholipid syndrome and HIV].
Santos JL; Cruz I; Martín Herrero F; Albarrán C; González Matas JM; Martín Luengo C
Rev Esp Cardiol; 2004 Oct; 57(10):997-9. PubMed ID: 15469799
[TBL] [Abstract][Full Text] [Related]
18. Perils in the thrombophilia workup: Frequency and circumstances of erroneously ordered factor V activity tests for thrombophilia.
Houghton DE; Sud S; Moll S; Rollins-Raval MA
Vasc Med; 2017 Dec; 22(6):527-528. PubMed ID: 28965480
[No Abstract] [Full Text] [Related]
19. Basilar artery thrombosis in a child heterozygous for factor V Leiden mutation.
Verdú A; Cazorla MR; Granados MA; Alonso JA; Casado LF
Pediatr Neurol; 2001 Jan; 24(1):69-71. PubMed ID: 11182285
[TBL] [Abstract][Full Text] [Related]
20. [21-year-old patient with myocardial infarct, transient cerebral ischemia and thrombocytopenia].
Rank A; Lindner L; Hiller E
Internist (Berl); 2003 Mar; 44(3):349-53. PubMed ID: 12731421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
